The VICC.ORG Directory of Cancers: Treatments, Services & Resources
Head and Neck Cancers
Although head and neck cancer is a common malignancy, there are few programs in the country that have dedicated, multidisciplinary teams to treat a large number of patients. The Vanderbilt-Ingram Cancer Center has a nationally recognized Head and Neck Cancer Program which is staffed by expert surgeons, a full-time medical oncologist and full-time radiation oncologists.
Types of Head and Neck Cancer
Clinical Trials for Head and Neck Cancers
19 Open Trials
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | ECOGTHNR1016 09/25/2012 | Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer |
| Therapeutic | ECOGTHNR0920 09/12/2012 | A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer |
| Therapeutic | ECOGTHNR1008 09/07/2012 | A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors |
| Therapeutic | VICCMD1188 06/08/2012 | An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers |
| Therapeutic | COGACNS0831 05/12/2011 | Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years. |
| Therapeutic | ECOGHNE1305 03/04/2009 | Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer. |
| Therapeutic | ECOGHNE1305-M 02/11/2009 | A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer |
| Correlative | VICCHN0603 04/28/2006 | Effect of PI3K Inhibition in HPV Infected Cell (deidentified) |
| Correlative | VICCHN0529 05/10/2005 | Novel Protein Regulator of Tumor Suppressor ARF & NF-kB (NIH/2 R01 DEO13173-05) (deidentified) |
| Correlative | VICCHN0530 04/08/2005 | Serum Biomarkers for Head & Neck Cancer (deidentified) |
| Correlative | VICCHN0356 02/04/2003 | Head and Neck Tumor Tissue Repository and Clinical Database |
| Epidemiology, Observation, Outcomes | VICCSUPP1224 11/19/2012 | Osteonecrosis of the Jaw Case (ONJ) Registry |
| Screen, Detect, Diagnose | VICCMD1286 12/17/2012 | Screening Protocol to Detect BRAF V600 Mutation Positive Patients for Enrollment into Clinical Research Studies of Vemurafenib |
| Supportive-Non-Therapeutic | VICCTHN1293 10/23/2012 | Comparative Musculoskeletal Impairment in Patients with Head and Neck Cancer Undergoing Surgical Reconstruction with Pectoralis Major Myocutaneous Flap Vs Revascularized Free Tissue Transfer |
| Supportive-Non-Therapeutic | VICCTHN1243 06/19/2012 | An Initial Study of Symptom Burden in Patients with Recurrent or Metastatic Head and Neck Cancer. |
| Supportive-Non-Therapeutic | VICCSUPP1236 05/22/2012 | Development of the Head and Neck Cancer Caregiving Task Inventory |
| Supportive-Non-Therapeutic | VICCSUPP1170 01/16/2012 | Effect of Manual Lymphatic Drainage on Dysphagia in Head and Neck Cancer Patients Status post Radiation Therapy without or without Concurrent Chemotherapy |
| Supportive-Therapeutic | VICCSUPP1232 07/17/2012 | A Feasibility Study to Evaluate Use of the Jaw Dynasplint? System to Prevent Trismus in Patients with Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy |
| Supportive-Therapeutic | VICCTHN1215 05/20/2012 | Validation of a Head and Neck Cancer Related Lymphedema Scale |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
